All In Biotech

Drug Trial Radar · NCT07932002

Exploring the Extended Efficacy and Initial Use of RUCONEST® in Managing Neurological Symptoms Linked to Infectious Pathogens

Assessment of RUCONEST® (C1 Esterase Inhibitor [Recombinant]) in Alleviating Neurological Symptoms Linked to Infectious Pathogens

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Nov 5, 2025

Primary completion

Jul 31, 2027

Study completion Oct 29, 2027

Sponsor

Lead sponsor
IMMUNOe Research CentersIndustry
Sponsor type
Industry
First posted
Nov 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assessment of RUCONEST (C1 Esterase Inhibitor \[Recombinant\]) in Alleviating Neurological Symptoms Linked to Infectious Pathogens

Conditions

  • Post SARS-CoV2 (COVID-19)
  • Post-Viral Fatigue Syndrome
  • Post-Viral Disorder (Disorder)
  • COVID - 19

Interventions

  • RuconestDrug

    IV Ruconest

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Neuropsychological Measures (BRIEF-A)Time frame: Week 0
  2. Neuropsychological Measures (BRIEF-A)Time frame: Week 5
  3. Neuropsychological Measures (BRIEF-A)Time frame: Week 9
  4. Neuropsychological Measures (BRIEF-A)Time frame: Week 13
  5. Neuropsychological Measures (BRIEF-A)Time frame: Week 17
  6. Neuropsychological Measures (BRIEF-A)Time frame: Week 21
  7. Neuropsychological Measures (BRIEF-A)Time frame: Week 25
  8. Neuropsychological Measures (RBANS)Time frame: Week 0
  9. Neuropsychological Measures (RBANS)Time frame: Week 5
  10. Neuropsychological Measures (RBANS)Time frame: Week 9
  11. Neuropsychological Measures (RBANS)Time frame: Week 13
  12. Neuropsychological Measures (RBANS)Time frame: Week 17
  13. Neuropsychological Measures (RBANS)Time frame: Week 21
  14. Neuropsychological Measures (RBANS)Time frame: Week 25
  15. Neuropsychological Measures (BDI II)Time frame: Week 0
  16. Neuropsychological Measures (BDI II)Time frame: Week 5
  17. Neuropsychological Measures (BDI II)Time frame: Week 9
  18. Neuropsychological Measures (BDI II)Time frame: Week 13
  19. Neuropsychological Measures (BDI II)Time frame: Week 17
  20. Neuropsychological Measures (BDI II)Time frame: Week 21
  21. Neuropsychological Measures (BDI II)Time frame: Week 25
  22. Neuropsychological Measures (MoCA)Time frame: Week 0
  23. Neuropsychological Measures (MoCA)Time frame: Week 5
  24. Neuropsychological Measures (MoCA)Time frame: Week 9
  25. Neuropsychological Measures (MoCA)Time frame: Week 13
  26. Neuropsychological Measures (MoCA)Time frame: Week 17
  27. Neuropsychological Measures (MoCA)Time frame: Week 21
  28. Neuropsychological Measures (MoCA)Time frame: Week 25
  29. Patient-Rated Questionnaire (FSS)Time frame: Week 0
  30. Patient-Rated Questionnaire (FSS)Time frame: Week 5
  31. Patient-Rated Questionnaire (FSS)Time frame: Week 9
  32. Patient-Rated Questionnaire (FSS)Time frame: Week 13
  33. Patient-Rated Questionnaire (FSS)Time frame: Week 17
  34. Patient-Rated Questionnaire (FSS)Time frame: Week 21
  35. Patient-Rated Questionnaire (FSS)Time frame: Week 25
  36. Patient-Rated Questionnaire (MIDAS)Time frame: Week 0
  37. Patient-Rated Questionnaire (MIDAS)Time frame: Week 5
  38. Patient-Rated Questionnaire (MIDAS)Time frame: Week 9
  39. Patient-Rated Questionnaire (MIDAS)Time frame: Week 13
  40. Patient-Rated Questionnaire (MIDAS)Time frame: Week 17
  41. Patient-Rated Questionnaire (MIDAS)Time frame: Week 21
  42. Patient-Rated Questionnaire (MIDAS)Time frame: Week 25
  43. Patient-Rated Questionnaire (HIT)Time frame: Week 0
  44. Patient-Rated Questionnaire (HIT)Time frame: Week 5
  45. Patient-Rated Questionnaire (HIT)Time frame: Week 9
  46. Patient-Rated Questionnaire (HIT)Time frame: Week 13
  47. Patient-Rated Questionnaire (HIT)Time frame: Week 17
  48. Patient-Rated Questionnaire (HIT)Time frame: Week 21
  49. Patient-Rated Questionnaire (HIT)Time frame: Week 25
  50. Patient-Rated Questionnaire (Activities)Time frame: Week 0
  51. Patient-Rated Questionnaire (Activities)Time frame: Week 5
  52. Patient-Rated Questionnaire (Activities)Time frame: Week 9
  53. Patient-Rated Questionnaire (Activities)Time frame: Week 13
  54. Patient-Rated Questionnaire (Activities)Time frame: Week 17
  55. Patient-Rated Questionnaire (Activities)Time frame: Week 21
  56. Patient-Rated Questionnaire (Activities)Time frame: Week 25
  57. Patient-Rated Questionnaire (SF)Time frame: Week 0
  58. Patient-Rated Questionnaire (SF)Time frame: Week 5
  59. Patient-Rated Questionnaire (SF)Time frame: Week 9
  60. Patient-Rated Questionnaire (SF)Time frame: Week 13
  61. Patient-Rated Questionnaire (SF)Time frame: Week 17
  62. Patient-Rated Questionnaire (SF)Time frame: Week 21
  63. Patient-Rated Questionnaire (SF)Time frame: Week 25
  64. Patient-Rated Questionnaire (GSRS)Time frame: Week 0
  65. Patient-Rated Questionnaire (GSRS)Time frame: Week 5
  66. Patient-Rated Questionnaire (GSRS)Time frame: Week 9
  67. Patient-Rated Questionnaire (GSRS)Time frame: Week 13
  68. Patient-Rated Questionnaire (GSRS)Time frame: Week 17
  69. Patient-Rated Questionnaire (GSRS)Time frame: Week 21
  70. Patient-Rated Questionnaire (GSRS)Time frame: Week 25
  71. Patient-Rated Questionnaire (SF-36)Time frame: Week 0
  72. Patient-Rated Questionnaire (SF-36)Time frame: Week 5
  73. Patient-Rated Questionnaire (SF-36)Time frame: Week 9
  74. Patient-Rated Questionnaire (SF-36)Time frame: Week 13
  75. Patient-Rated Questionnaire (SF-36)Time frame: Week 17
  76. Patient-Rated Questionnaire (SF-36)Time frame: Week 21
  77. Patient-Rated Questionnaire (SF-36)Time frame: Week 25
  78. Neurological ExamTime frame: Week 0
  79. Neurological ExamTime frame: Week 5
  80. Neurological ExamTime frame: Week 9
  81. Neurological ExamTime frame: Week 13
  82. Neurological ExamTime frame: Week 17
  83. Neurological ExamTime frame: Week 21
  84. Neurological ExamTime frame: Week 25

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • IMMUNOe Research Centers

    Centennial, Colorado · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.